GR3003081T3 - Agent for the prophylaxis of a heart infarct and for the prevention of another infarct - Google Patents

Agent for the prophylaxis of a heart infarct and for the prevention of another infarct

Info

Publication number
GR3003081T3
GR3003081T3 GR91401693T GR910401693T GR3003081T3 GR 3003081 T3 GR3003081 T3 GR 3003081T3 GR 91401693 T GR91401693 T GR 91401693T GR 910401693 T GR910401693 T GR 910401693T GR 3003081 T3 GR3003081 T3 GR 3003081T3
Authority
GR
Greece
Prior art keywords
infarct
agent
prophylaxis
prevention
another
Prior art date
Application number
GR91401693T
Other languages
Greek (el)
English (en)
Inventor
Joachim Dr Helbig
Hans Georg Prof Dr Classen
Original Assignee
Verla Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verla Pharm filed Critical Verla Pharm
Publication of GR3003081T3 publication Critical patent/GR3003081T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR91401693T 1988-05-02 1991-11-07 Agent for the prophylaxis of a heart infarct and for the prevention of another infarct GR3003081T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3814856A DE3814856A1 (de) 1988-05-02 1988-05-02 Mittel zur prophylaxe des herzinfarkts und zur verhuetung des reinfarkts

Publications (1)

Publication Number Publication Date
GR3003081T3 true GR3003081T3 (en) 1993-02-17

Family

ID=6353393

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91401693T GR3003081T3 (en) 1988-05-02 1991-11-07 Agent for the prophylaxis of a heart infarct and for the prevention of another infarct

Country Status (7)

Country Link
US (1) US5006516A (enExample)
EP (1) EP0340540B1 (enExample)
AT (1) ATE68973T1 (enExample)
DE (2) DE3814856A1 (enExample)
ES (1) ES2039735T3 (enExample)
GR (1) GR3003081T3 (enExample)
ZA (1) ZA893244B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4335441A1 (de) * 1993-10-18 1995-04-20 Hans Dipl Chem Heide Mittel zur Gesundheitsvorsorge im Herz- Kreislaufsystem beim Menschen
US20040214884A1 (en) * 2003-04-28 2004-10-28 Hagen Brent P. Method for supplementing magnesium in an animal
US7041286B2 (en) * 2003-07-23 2006-05-09 Nerenberg Arnold P Composition for mitigating a pernicious thrombotic event
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
JP7493449B2 (ja) 2017-09-22 2024-05-31 ヴェクチュラ インコーポレイテッド ステアリン酸マグネシウムを含む乾燥粉末組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1809119C3 (de) * 1968-11-15 1973-12-20 Verla-Pharm Arzneimittelfabrik, Apotheker H.J.V.Ehrlich, 8132 Tutzing Infarktprophylaktikum
DE2228101C3 (de) * 1972-06-09 1979-07-05 Verla-Pharm. Arzneimittelfabrik, Apotheker H.J. V. Ehrlich, Gmbh & Co Kg, 8132 Tutzing Verfahren zur Gewinnung von Komplexverbindungen aus Aminodicarbonsäureionen, Magnesiumionen und Halogenidionen
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
DE3238118A1 (de) * 1982-10-14 1984-04-19 Verla-Pharm, Arzneimittelfabrik Apotheker H.J. v. Ehrlich GmbH & Co KG, 8132 Tutzing Verfahren zur herstellung von komplexverbindungen aus aminodicarbonsaeuren, zweiwertigen metallionen und halogenidionen
DE3340873A1 (de) * 1983-11-11 1985-05-23 ARTESAN GmbH Fabrik chemisch-pharmazeutischer Präparate, 3130 Lüchow Verwendung von magnesium-salicylat oder magnesium-acetylsalicylat

Also Published As

Publication number Publication date
ES2039735T3 (es) 1993-10-01
DE3814856A1 (de) 1989-11-16
US5006516A (en) 1991-04-09
EP0340540A3 (en) 1990-03-21
EP0340540B1 (de) 1991-10-30
EP0340540A2 (de) 1989-11-08
ATE68973T1 (de) 1991-11-15
DE58900410D1 (de) 1991-12-05
DE3814856C2 (enExample) 1992-02-20
ZA893244B (en) 1990-01-31

Similar Documents

Publication Publication Date Title
DE58901934D1 (de) Verschlussanordnung fuer pharmazeutische flaschen.
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
CA2019974A1 (en) Treatment of inflammation
DE3882077D1 (de) Waermestabilisierte copolymerzusammensetzung.
EP0493408A4 (en) Oral anticoagulant/platelet inhibitor low dose formulation
USD285540S (en) Transit reticle or similar article
EP0497258A3 (en) Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
IL86313A (en) Three-layered composition for use on a pharmaceutical granule
GB2223107B (en) Non-contact tonometer
DK233088A (da) Peptid med beskyttet c-terminal alfa-carboxylgruppe eller fysiologiske acceptable salte deraf, dets fremstilling og anvendelse som farmaceutikum
ZA901674B (en) Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure(7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
EP0340540A3 (en) Agent for the prophylaxis of a heart infarct and for the prevention of another infarct
RU93041779A (ru) Средство для лечения иммунодефицитных состояний
IL111817A0 (en) Halogen-containing metal complexes, diagnostic agents containing the same and processes for the preparation thereof
DK0624375T3 (da) Hirudin-holdige farmaceutiske præparater
IL81549A0 (en) Pharmaceutical compositions containing glycerophosphoryl-o-serine or a salt thereof,certain such novel salts and their preparation
ZA93694B (en) Pharmaceutical treatments.
GR3005531T3 (enExample)
ZA894173B (en) Antiviral pharmaceutical composition
CA2057456A1 (en) Anti depression pharmaceutical
CA2153975A1 (en) Marker for crohn's disease and multiple sclerosis
GB2219501B (en) Nootropic agent.
ZA927100B (en) The use of L-carnitine in endangered pregnacy.
陈钢 I am dirty"," Mywife is dirty too
郭映春 et al. A CASE STUDIES SWALLOWING-INDUCED CARDIAC ARRHYTHMIA